CORCEPT THERAPEUTICS INC ($CORT)
Filing Information
| Accession Number | 0001193125-26-414684 |
|---|---|
| Form Type | 4 |
| Filing Date | Oct 5, 2026 |
| Document | View SEC Filing |
Transactions
9
Total Shares
30,000
Total Value
$1,329,578.83
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Accounting&Technology Officer | Common Stock | โ | Oct 1, 2026 | Exercise/Conversion | 810 | $13.56 | $10,983.60 | 6,493 | Direct | โ | View Details | |
Chief Accounting&Technology Officer | Common Stock | โ | Oct 1, 2026 | Sale | 810 | $115.40 | $93,472.79 | 5,683 | Direct | โ | View Details | |
Chief Accounting&Technology Officer | Common Stock | โ | Oct 2, 2026 | Exercise/Conversion | 3,357 | $13.56 | $45,520.92 | 9,040 | Direct | โ | View Details | |
Chief Accounting&Technology Officer | Common Stock | โ | Oct 2, 2026 | Exercise/Conversion | 5,833 | $19.26 | $112,343.58 | 14,873 | Direct | โ | View Details | |
Chief Accounting&Technology Officer | Common Stock | โ | Oct 2, 2026 | Sale | 4,446 | $115.70 | $514,388.86 | 10,427 | Direct | โ | View Details | |
Chief Accounting&Technology Officer | Common Stock | โ | Oct 2, 2026 | Sale | 4,744 | $116.54 | $552,869.08 | 5,683 | Direct | โ | View Details | |
Chief Accounting&Technology Officer | Stock option (right to buy) | Derivative | Oct 1, 2026 | Exercise/Conversion | 810 | $0.00 | $0.00 | 3,357 | Direct | โ | View Details | |
Chief Accounting&Technology Officer | Stock option (right to buy) | Derivative | Oct 2, 2026 | Exercise/Conversion | 3,357 | $0.00 | $0.00 | 0 | Direct | โ | View Details | |
Chief Accounting&Technology Officer | Stock option (right to buy) | Derivative | Oct 2, 2026 | Exercise/Conversion | 5,833 | $0.00 | $0.00 | 44,167 | Direct | โ | View Details |